Capvizr

Syrian healthtech Moadna Secures $50 Thousand in Latest Pre-Seed Funding Round

Capvizr Staff · · 2 min read

Syrian healthtech Moadna secured $50 thousand in its latest Pre-Seed, adding another data point to the Healthcare & Life Sciences funding market.

Pre-Seed$50 thousandHealthcare & Life SciencesUndisclosed HQ

Syrian healthtech Moadna Raises $50 thousand in Funding

Syrian healthtech Moadna raises $50,000 in early-stage funding. The platform serves over 550 clinics and has more than 8,000 users.

Investors Behind the Funding

The round was backed by angel investors, raising the company's valuation. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Syrian healthtech Moadna operates in Healthcare & Life Sciences. Syrian healthtech Moadna's Pre-Seed round shows investors are still backing digital health platforms with real scale narratives. At $0M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

Manage appointments, patient records, medical visits, billing, revenues, and expenses, while also offering digital booking and patient communication services.

Looking Ahead

Syrian healthtech Moadna raises $50,000 in early-stage funding

Source reference: original announcement/article.

View Syrian healthtech Moadna's full profile and funding history on Capvizr →